You are here » Home » Companies » Company Overview » Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd.

BSE: 500420	Sector: Health care
NSE: TORNTPHARM	ISIN Code: INE685A01028

BSE 14:06 | 22 Jun

2920.35

1.85
(0.06%)

OPEN

2915.15

HIGH

2924.25

LOW

2886.40

NSE 13:59 | 22 Jun

2920.95

0.55
(0.02%)

OPEN

2926.25

HIGH

2926.25

LOW

2885.05

Add to Watchlist | Add to Portfolio

OPEN	2915.15
PREVIOUS CLOSE	2918.50
VOLUME	3825
52-Week high	3040.00
52-Week low	2232.00
P/E	43.43
Mkt Cap.(Rs cr)	49,418
Buy Price	2920.10
Buy Qty	33.00
Sell Price	2921.65
Sell Qty	1.00

OPEN	2915.15
CLOSE	2918.50
VOLUME	3825
52-Week high	3040.00
52-Week low	2232.00
P/E	43.43
Mkt Cap.(Rs cr)	49,418
Buy Price	2920.10
Buy Qty	33.00
Sell Price	2921.65
Sell Qty	1.00

Click here for interactive graph

Torrent Pharmaceuticals Ltd. (TORNTPHARM) - Latest News & Headlines

Hope to launch diabetic NCE by next financial year: Torrent Pharma's Mehta

12.00 am | 5 Jun 2021 | Business Standard

We would also look into distribution opportunities to bring some of these products into the market, said Mehta
Sensex slips 291 pts amid weak global cues; pharma, PSB stocks rally

4.18 pm | 19 May 2021 | Business Standard

Coal India, Cipla, Sun Pharma, UPL, Nestle India, Indian Oil Corporation, Tech M, Axis Bank, and SBI Life were the top gainers of the day
Torrent Pharma shares rise 6% post March quarter results

10.48 am | 19 May 2021 | Business Standard

HDFC Securities said that Torrent's Q4 results were largely in line with their estimates as strong trends in India and Germany offset weak US
Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high

12.24 pm | 10 May 2021 | Business Standard

Since April, the Nifty Pharma index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50 index
Short-term trend in Nifty bearish, stay stock-specific: Vinay Rajani

9.04 am | 3 Mar 2021 | Business Standard

The trend of midcap and smallcap stocks has been strong and stock specific bullishness is likely to continue
Weak US outlook in near term, higher costs to weigh on Torrent Pharma

12.38 am | 10 Feb 2021 | Business Standard

While the stock has corrected, valuations leave little room for upside
Torrent Pharma shares tumble 8% post December quarter results

1.08 pm | 9 Feb 2021 | Business Standard

While the outlook for its key geographies is expected to improve over the medium term, the current valuation largely captures the upside, analysts sai...
Torrent Pharma Q3 net up by 18% to Rs 297 cr even as US revenues dip

10.45 pm | 8 Feb 2021 | Business Standard

India revenues grew 7% to stand at Rs 930 cr. Company's consolidated total revenue from operations fell marginally by under 1% to Rs 2,003 cr in Q3FY2...
Nifty Pharma index surges 4%; Sun Pharma, Cipla hit 52-week highs

1.32 pm | 3 Feb 2021 | Business Standard

At 12:57 pm, Nifty Pharma index, the top gainer among sectoral indices, was up 4.2 per cent, as compared to 1.3 per cent gain in the benchmark Nifty50...